These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10529852)

  • 21. Atrial response to ventricular antitachycardia pacing discriminates mechanism of 1:1 atrioventricular tachycardia.
    Ridley DP; Gula LJ; Krahn AD; Skanes AC; Yee R; Brown ML; Olson WH; Gillberg JM; Klein GJ
    J Cardiovasc Electrophysiol; 2005 Jun; 16(6):601-5. PubMed ID: 15946356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Food and Drug Administration and atrial defibrillation devices.
    Chen L; Keane AT; Every NR
    Am J Manag Care; 1999 Jul; 5(7):899-909. PubMed ID: 10557410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lower body mass index and atrial fibrillation as independent predictors for mortality in patients with implantable cardioverter defibrillator.
    Schernthaner C; Pichler M; Strohmer B
    Croat Med J; 2007 Feb; 48(1):59-67. PubMed ID: 17309140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversal of remodeling in atrial fibrillation: a positive double-negative?
    George Wyse D
    J Cardiovasc Electrophysiol; 2004 May; 15(5):513-4. PubMed ID: 15149417
    [No Abstract]   [Full Text] [Related]  

  • 25. The role of complex fractionated atrial electrograms in atrial fibrillation ablation moving to the beat of a different drum.
    Nademanee K; Oketani N
    J Am Coll Cardiol; 2009 Mar; 53(9):790-1. PubMed ID: 19245971
    [No Abstract]   [Full Text] [Related]  

  • 26. Long-term care of the patient with the atrial defibrillator.
    Mitchell AR; Spurrell PA; Boodhoo LE; Sulke N
    Am Heart J; 2004 Feb; 147(2):210-7. PubMed ID: 14760315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ventricular asystole during atrial antitachycardia pacing by implanted cardioverter-defibrillator.
    Herweg B; Barold SS
    Pacing Clin Electrophysiol; 2005 May; 28(5):432-3. PubMed ID: 15869677
    [No Abstract]   [Full Text] [Related]  

  • 28. Results of the multicenter RENEWAL 3 AVT clinical study of cardiac resynchronization defibrillator therapy in patients with paroxysmal atrial fibrillation.
    Saxon LA; Greenfield RA; Crandall BG; Nydegger CC; Orlov M; VAN Genderen R
    J Cardiovasc Electrophysiol; 2006 May; 17(5):520-5. PubMed ID: 16684026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Choosing a treatment strategy for atrial fibrillation.
    Harv Heart Lett; 2001 May; 11(9):1-4. PubMed ID: 11410433
    [No Abstract]   [Full Text] [Related]  

  • 30. Atrial fibrillation in the new millennium--the role of pacemaker and defibrillator therapy.
    Mitchell AR
    Med Sci Monit; 2002 Oct; 8(10):RA233-9. PubMed ID: 12388933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of atrial arrhythmias secondary to severe congenital heart disease with the Atrioverter.
    Timmermans C; Rodriguez LM; Reuter D; Stappers J; Barenbrug PJ; Cheriex EC; Wellens HJ
    Pacing Clin Electrophysiol; 2000 Jul; 23(7):1181-3. PubMed ID: 10914379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electrical and pharmacologic cardioversion for atrial fibrillation.
    Kim SS; Knight BP
    Cardiol Clin; 2009 Feb; 27(1):95-107, ix. PubMed ID: 19111767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is atrial remodeling a viable target for prevention of atrial fibrillation recurrence?
    Nattel S
    J Cardiovasc Electrophysiol; 2004 Aug; 15(8):885-6. PubMed ID: 15333079
    [No Abstract]   [Full Text] [Related]  

  • 34. [How experimental models have influenced our physiopathological knowledge of a possible therapeutic approach to atrial fibrillation].
    Capucci A; Villani GQ; Aschieri D
    Cardiologia; 1998 Aug; 43(8):789-92. PubMed ID: 9808868
    [No Abstract]   [Full Text] [Related]  

  • 35. Rate control vs rhythm control strategies in atrial fibrillation.
    Wyse DG
    Prog Cardiovasc Dis; 2005; 48(2):125-38. PubMed ID: 16253652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atrial fibrillation: the nonpharmacologic strategy.
    Lee J
    Mt Sinai J Med; 2002 Sep; 69(4):232-41. PubMed ID: 12357264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peering through the looking glass: electrical therapy for atrial fibrillation in 2004--where do we stand?
    Zaim S; Saksena S
    J Cardiovasc Electrophysiol; 2004 Apr; 15(4):496-500. PubMed ID: 15090001
    [No Abstract]   [Full Text] [Related]  

  • 38. Selection of drugs in pursuit of rate control strategy.
    Samii SM; Hynes BJ; Khan M; Wolbrette DL; Luck JC; Naccarelli GV
    Prog Cardiovasc Dis; 2005; 48(2):146-52. PubMed ID: 16253654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of pacemaker and defibrillator therapy for the treatment of atrial fibrillation.
    Mitchell AR
    Minerva Cardioangiol; 2004 Apr; 52(2):141-53. PubMed ID: 15194995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atrial fibrillation: can we cure it if we can't explain it?
    Sung RJ; Lauer MR
    J Cardiovasc Electrophysiol; 2005 May; 16(5):505-7. PubMed ID: 15877621
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.